Author | Martin S. Tallman, MD | OncLive

Author | Martin S. Tallman, MD

Articles

Dr. Tallman on FDA Approval of Midostaurin in AML

April 29, 2017

Video

Martin S. Tallman, MD, chief, Leukemia Service, Memorial Sloan Kettering Cancer Center, discusses the FDA approval of midostaurin (PKC412) for adult patients with newly diagnosed FLT3-mutated acute myeloid leukemia (AML).

Dr. Tallman on the State of the Science in AML Treatment

February 17, 2017

Video

Martin S. Tallman, MD, hematologic oncologist, chief of Leukemia Service, Memorial Sloan Kettering Cancer Center, discusses the state of the science with regards to treatment of patients with acute myeloid leukemia (AML).

Dr. Tallman on BRAF Inhibitors for the Treatment of HCL

January 08, 2014

Video

Martin S. Tallman, MD, Chief, Leukemia Service, Memorial Sloan-Kettering Cancer Center, discusses the treatment of hairy cell leukemia (HCL) with a BRAF inhibitor.

x